Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
M. P. Udumula, F. Rashid, H. Singh, T. Pardee, S. Luther, T. Bhardwaj, K. Anjaly, S. Piloni, M. Hijaz, R. Gogoi, P. A. Philip, A. Munkarah, s. Giri, R. Rattan
This study shows CPI-613 reduces tumor growth in chemoresistant ovarian tumors by inhibiting mitochondrial function and enhancing chemotherapy response.
bioRxiv · May 16, 2024Cancer Biology